These Money Losses Won't Help You at Tax Time
How to Save and Invest for a House Down Payment
8 Signs You're a Shopaholic and What to Do About It
Last Week's Biggest Stock Movers
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.